Acarbose (Page 4 of 4)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (25mg)

NDC 23155-147 -01

Acarbose Tablets, USP

25 mg

100 Tablets

Rx only

25 mg label
(click image for full-size original)
25 mg
(click image for full-size original)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (50mg)

NDC 23155-148 -01

Acarbose Tablets, USP

50 mg

100 Tablets

Rx only

50 mg label revised
(click image for full-size original)

50 mg label
(click image for full-size original)

PACKAGE LABEL PRINCIPAL DISPLAY PANEL (100mg)

NDC 23155-149 -01

Acarbose Tablets, USP

100 mg

100 Tablets

Rx only

100 mg revised
(click image for full-size original)
100 mg label
(click image for full-size original)
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-147
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 25 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 6mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-147-05 500 TABLET in 1 BOTTLE None
2 NDC:23155-147-01 100 TABLET in 1 BOTTLE None
3 NDC:23155-147-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-148
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 50 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 7mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-148-05 500 TABLET in 1 BOTTLE None
2 NDC:23155-148-01 100 TABLET in 1 BOTTLE None
3 NDC:23155-148-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
ACARBOSE acarbose tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:23155-149
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACARBOSE (ACARBOSE) ACARBOSE 100 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MICROCRYSTALLINE CELLULOSE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 9mm
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:23155-149-01 100 TABLET in 1 BOTTLE None
2 NDC:23155-149-05 500 TABLET in 1 BOTTLE None
3 NDC:23155-149-10 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA202271 04/16/2021
Labeler — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (780779901)
Registrant — AVET LIFESCIENCES PRIVATE LIMITED (853181664)
Establishment
Name Address ID/FEI Operations
RA CHEM PHARMA LIMITED 677637710 MANUFACTURE (23155-147), MANUFACTURE (23155-148), MANUFACTURE (23155-149)
Establishment
Name Address ID/FEI Operations
CorePharma, LLC 031192276 manufacture (23155-147), manufacture (23155-148), manufacture (23155-149)

Revised: 03/2023 Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.